We are a stem cell company specializing in induced pluripotent stem cell (iPSC)-based platforms for rare neurological diseases.

Founded at ODTÜ Teknokent with the support of the TÜBİTAK BİGG fund (TEYDEB 1812), TiPS Cell set out to make a difference in the field of medical biotechnology.

About Us

Our Mission

TiPS Cell provide high-quality, high efficiency induced pluripotent stem cell (iPSC)-based models to researchers for disease modeling, drug screening and regenerative medicine research.

Research Products

Our research team, bringing years of experience in iPSC reprogramming, generates induced pluripotent stem cell (iPSC)-based disease models for rare neurological diseases and utilizes these platforms to develop innovative small-molecule drugs, cell therapies, and gene therapies.